FREE Account Opening + No Clearing Fees
Loading...

Hemant Surgical Industries IPO vs Remus Pharmaceuticals IPO

Comparision between Hemant Surgical Industries IPO and Remus Pharmaceuticals IPO.

IPO Details

Hemant Surgical Industries IPO is a SME Book Built Issue IPO proposed to list at BSE SME while Remus Pharmaceuticals IPO is a SME Book Built Issue proposed to list at NSE SME.

  Hemant Surgical Industries IPO Remus Pharmaceuticals IPO
Logo Hemant Surgical Industries IPO Logo Remus Pharmaceuticals IPO Logo
Issue Category SME SME
Issue Type IPO IPO
Process Type Book Built Issue Book Built Issue
Listing At BSE SME NSE SME
Lead Managers Hem Securities Limited Beeline Capital Advisors Pvt Ltd
Registrar Bigshare Services Pvt Ltd Link Intime India Private Ltd
Market Maker Hem Finlease Private Limited Sunflower Broking Private Limited
DRHP DRHP DRHP
RHP RHP RHP
Anchor Investor Anchor Investor Anchor Investor
IPO Allotment URL IPO Allotment URL IPO Allotment URL

Issue Size and Price

The total issue size of Hemant Surgical Industries IPO is up to ₹24.84 Cr whereas the issue size of the Remus Pharmaceuticals IPO is up to ₹47.69 Cr. The final issue price of Hemant Surgical Industries IPO is ₹90.00 per share and of Remus Pharmaceuticals IPO is ₹1,229.00 per share.

  Hemant Surgical Industries IPO Remus Pharmaceuticals IPO
Face Value ₹10 per share ₹10 per share
Issue Price (Lower) ₹85.00 per share ₹1,150.00 per share
Issue Price (Upper) ₹90.00 per share ₹1,229.00 per share
Issue Price (Final) ₹90.00 per share ₹1,229.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size 1600 shares 100 shares
Fresh Issue Size 27,60,000 shares 3,88,000 shares
Fresh Issue Size (Amount) up to ₹24.84 Cr up to ₹47.69 Cr
OFS Issue Size
OFS Issue Size (Amount)
Issue Size Total 27,60,000 shares 3,88,000 shares
Issue Size Total (Amount) up to ₹24.84 Cr up to ₹47.69 Cr

IPO Timetable

Hemant Surgical Industries IPO opens on May 24, 2023, while Remus Pharmaceuticals IPO opens on May 17, 2023. The closing date of Hemant Surgical Industries IPO and Remus Pharmaceuticals IPO is May 26, 2023, and May 19, 2023, respectively.

  Hemant Surgical Industries IPO Remus Pharmaceuticals IPO
Anchor Bid Date May 23, 2023 May 16, 2023
Issue Open May 24, 2023 May 17, 2023
Issue Close May 26, 2023 May 19, 2023
Basis Of Allotment (Tentative) May 31, 2023 May 24, 2023
Initiation of Refunds (Tentative) Jun 01, 2023 May 25, 2023
Credit of Share (Tentative) Jun 02, 2023 May 26, 2023
Listing date (Tentative) Jun 05, 2023 May 29, 2023
Anchor Lockin End date 1 Jun 30, 2023 Jun 23, 2023
Anchor Lockin End date 2 Aug 29, 2023 Aug 22, 2023

Financials

Hemant Surgical Industries IPO P/E ratio is 12.28, as compared to Remus Pharmaceuticals IPO P/E ratio of 21.09.

  Hemant Surgical Industries IPO Remus Pharmaceuticals IPO
Financial
Hemant Surgical Industries Limited Financial Information (Restated)
Period EndedTotal AssetsTotal RevenueProfit After TaxNet WorthReserves and SurplusTotal Borrowing
31-Mar-214,289.846,065.19114.53836.61653.381,446.35
31-Mar-225,437.5910,577.02461.401,298.011,114.78973.80
31-Mar-236,490.7911,149.68765.112,359.901,591.90711.92
Amount in ₹ Lakhs
Remus Pharmaceuticals Limited Financial Information (Restated)
Period EndedTotal AssetsTotal RevenueProfit After TaxNet WorthReserves and SurplusTotal Borrowing
31-Mar-20530.361,276.8981.16202.03201.0335.93
31-Mar-211,104.961,922.45102.58304.61303.6127.89
31-Mar-221,590.932,543.71338.57643.17543.1719.17
31-Dec-223,352.963,361.20643.901,712.071,603.57947.45
Amount in ₹ Lakhs
Promoter Shareholding (Pre-Issue) 100.00% 92.82%
Promoter Shareholding (Post-Issue) 73.56% 68.37%
P/E Ratio 12.28 21.09
Market Cap ₹93.96 Cr. ₹181.03 Cr.
ROE 32.42%% 71.44%%
ROCE 37.98%% 69.99%%
Debt/Equity 0.3 0.03
EPS ₹10.26 ₹33.86
RoNW 32.42%% 52.64%%

Shares Offered

In the Hemant Surgical Industries IPO retail investors (RII) are offered 9,16,800 shares while in Remus Pharmaceuticals IPO retail investors are offered 9,16,800 shares. Qualified institutional buyers (QIB) are offered 5,23,200 shares in Hemant Surgical Industries IPO and 1,38,750 shares in Remus Pharmaceuticals IPO.

  Hemant Surgical Industries IPO Remus Pharmaceuticals IPO
Anchor Investor Reserveration 7,82,400 shares 1,10,500 shares
Market Maker Reserveration 1,44,000 shares 19,500 shares
QIB 5,23,200 shares 1,38,750 shares
NII 3,93,600 shares 41,625 shares
RII 9,16,800 shares 97,125 shares
Employee 0 shares 0 shares
Others
Total 18,33,600 shares 2,77,500 shares

Bids Received (Subscription)

Hemant Surgical Industries IPO subscribed 150.59x in total, whereas Remus Pharmaceuticals IPO subscribed 57.21x.

  Hemant Surgical Industries IPO Remus Pharmaceuticals IPO
QIB (times) 41.05x 10.75x
NII (times) 277.26x 229.31x
Big NII (times)
Small NII (times)
RII (times) 158.73x 49.81x
Employee (times)
Other (times)
Total (times) 150.59x 57.21x

Comments

Add a public comment...